These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1928011

  • 1. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM, Lee PD, Morris AH, Reiter EO, Gertner JM, Marcus R, Quarmby VE, Rosenfeld RG.
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [Abstract] [Full Text] [Related]

  • 2. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G, Baroncelli GI, Bertelloni S, Perri G.
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [Abstract] [Full Text] [Related]

  • 3. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK.
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [Abstract] [Full Text] [Related]

  • 4. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ.
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [Abstract] [Full Text] [Related]

  • 5. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL.
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [Abstract] [Full Text] [Related]

  • 6. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
    Rivkees SA, el-Hajj-Fuleihan G, Brown EM, Crawford JD.
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
    [Abstract] [Full Text] [Related]

  • 7. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
    Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G.
    J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622
    [Abstract] [Full Text] [Related]

  • 8. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [Abstract] [Full Text] [Related]

  • 9. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH, Marie PJ, Pettifor JM, Delvin EE.
    N Engl J Med; 1980 Oct 30; 303(18):1023-31. PubMed ID: 6252463
    [Abstract] [Full Text] [Related]

  • 10. [Growth hormone treatment of familial hypophosphatemic rickets].
    Saggese G, Baroncelli GI, Barsanti S.
    Arch Pediatr; 1998 Oct 30; 5 Suppl 4():360S-363S. PubMed ID: 9853084
    [Abstract] [Full Text] [Related]

  • 11. Extremely low serum pyridoxal 5'-phosphate in children with familial hypophosphatemic rickets.
    Reynolds RD, Lorenc RS, Wieczorek E, Pronicka E.
    Am J Clin Nutr; 1991 Mar 30; 53(3):698-701. PubMed ID: 2000825
    [Abstract] [Full Text] [Related]

  • 12. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE, Glorieux FH.
    Calcif Tissue Int; 1981 Mar 30; 33(2):173-5. PubMed ID: 6260313
    [Abstract] [Full Text] [Related]

  • 13. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whyte MP.
    J Bone Miner Res; 1992 Jun 30; 7(6):583-97. PubMed ID: 1414477
    [Abstract] [Full Text] [Related]

  • 14. Familial hypophosphatemic rickets: bone mass measurements in children following therapy with calcitriol and supplemental phosphate.
    Block JE, Piel CF, Selvidge R, Genant HK.
    Calcif Tissue Int; 1989 Feb 30; 44(2):86-92. PubMed ID: 2492895
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone therapy in a poorly growing child with hypophosphatemic rickets.
    Lanes R, Harrison HE.
    J Endocrinol Invest; 1990 Nov 30; 13(10):833-7. PubMed ID: 2096160
    [Abstract] [Full Text] [Related]

  • 16. Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets.
    Bettinelli A, Bianchi ML, Mazzucchi E, Gandolini G, Appiani AC.
    J Pediatr; 1991 Mar 30; 118(3):372-6. PubMed ID: 1847972
    [Abstract] [Full Text] [Related]

  • 17. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG, Brown R, Baum M.
    Pediatrics; 1997 Nov 30; 100(5):879-84. PubMed ID: 9346990
    [Abstract] [Full Text] [Related]

  • 18. Renal hypophosphatemic rickets - a review.
    Chan JC.
    Int J Pediatr Nephrol; 1982 Dec 30; 3(4):305-10. PubMed ID: 6762360
    [No Abstract] [Full Text] [Related]

  • 19. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets.
    Glorieux FH.
    Metabolism; 1990 Apr 30; 39(4 Suppl 1):10-2. PubMed ID: 2157942
    [Abstract] [Full Text] [Related]

  • 20. [Familial hypophosphatemic rickets. Effects of treatment with 1,25-dihydroxycholecalciferol at supraphysiologic doses].
    Saggese G, Baroncelli GI, Bertelloni S, Federico G.
    Minerva Pediatr; 1987 May 31; 39(10):451-5. PubMed ID: 3657736
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.